Medley posted a sharp jump in first-half profit and, separately, moved to lock in a bigger slice of Japan's healthcare-staffing market: borrowing ¥5.0bn from two banks in January and taking full ownership of the business behind Recruit Medical Career in August, weeks after its books for the half had already closed.
Net sales for the six months to June 30, 2026 rose 22.8% year-on-year to ¥22.7bn, up from ¥18.5bn a year earlier. Medley disclosed the results in a semiannual securities report filed with Japan's Kanto Local Finance Bureau on August 13, 2026. Operating profit climbed 67.4% to ¥2.4bn, ordinary income rose 77.6% to ¥2.8bn, and net profit attributable to shareholders jumped 131.2% to ¥1.5bn. EBITDA reached ¥3.9bn, up 43.4%.
The gains came almost entirely from Job Medley, the company's recruitment platform for healthcare and caregiving employers. The HR Platform segment's revenue rose 24.4% to ¥16.7bn, and its operating profit, calculated before allocation of shared corporate costs, grew 29.2% to ¥6.2bn. The number of client worksites using the platform rose 3.8% from the prior fiscal year-end to 466,000, and listed job postings climbed 1.3% to 477,000.
| Segment | Sales (H1) | Sales YoY | Operating result (H1) |
|---|---|---|---|
| HR Platform | ¥16.7bn | +24.4% | ¥6.2bn profit (+29.2%) |
| Medical Platform | ¥5.5bn | +22.8% | ¥484mn loss (vs ¥51mn loss a year earlier) |
| New Service Development | ¥513mn | -12.9% | ¥385mn loss (vs ¥349mn loss a year earlier) |
The Medical Platform segment, which sells hospital and clinic software including MEDLEY AI CLOUD, also grew revenue 22.8% to ¥5.5bn as the number of client medical institutions rose 2.1% to 23,000. But the segment's operating loss widened to ¥484mn from ¥51mn a year earlier. Medley attributed the wider loss to prioritizing revenue growth over near-term profitability across the segment as a whole, not to any single product line.
A smaller New Service Development segment, covering an early-stage US hiring platform and the nursing-home search site Minkai (which absorbed the Kaigo no Honne brand from January 2026), posted revenue of ¥513mn, down 12.9% after Medley sold its Guppy Healthcare business. That segment's operating loss widened to ¥385mn from ¥349mn, which the company linked to investment in expanding its US operations.
Behind the growth, Medley has been rearranging its balance sheet. On January 30, 2026, it drew ¥5.0bn in combined five-year loans from Mizuho Bank and Sumitomo Mitsui Banking Corporation, earmarked for working capital and treasury-share purchases. Then, on August 3, 2026, after the interim period had closed, Medley completed the acquisition of all shares in RM Career, the entity holding the operating business of Recruit Medical Career. The report does not disclose a purchase price or integration terms for that deal, and because it closed after period-end, none of the reported first-half figures include any contribution from RM Career.
Total assets stood at ¥45.4bn at period-end, up ¥4.1bn from the prior fiscal year-end, with cash and equivalents at ¥12.0bn. Total liabilities rose to ¥30.4bn, reflecting in part the new bank borrowings and a larger current portion of long-term debt.